G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska +12 more2021Signal Transduction and Targeted TherapyReview
Ocular
Abstract
As one of the most successful therapeutic target families, G protein-coupled receptors (GPCRs) have experienced a transformation from random ligand screening to knowledge-driven drug design. We are eye-witnessing tremendous progresses made recently in the understanding of their structure-function relationships that facilitated drug development at an unprecedented pace. This article intends to provide a comprehensive overview of this important field to a broader readership that shares some common interests in drug discovery.
Related Papers
- Multifaceted mitochondrial as a novel therapeutic target in dry eye: insights and interventionsCell Death Discovery · 2024 · 1 shared tag
- Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological MechanismsClinical Reviews in Allergy & Immunology · 2025 · 1 shared tag
- A Narrative Review of the Immunomodulatory Effects of Acthar® Gel Beyond Its Steroidogenic PropertiesAdvances in Therapy · 2025 · 1 shared tag
- Immunomodulatory Role of Neuropeptides in the CorneaBiomedicines · 2022 · 1 shared tag
- Novel Method for Assessing the Protection Lifetime of Building Coatings against FungiCoatings · 2023 · 1 shared tag
- In silico design of a TLR4-mediating multiepitope chimeric vaccine against amyotrophic lateral sclerosis via advanced immunoinformaticsJournal of Leukocyte Biology · 2022 · 1 shared tag